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Abstract
After the initial mechanical insult of spinal cord injury (SCI), secondary mediators propagate a 
massive loss of oligodendrocytes. We previously showed that following SCI both the total 
phospholipases activity and cytosolic PLA2-IVα protein expression increased. However, the 
expression of secreted isoforms of PLA2 (sPLA2) and their possible roles in oligodendrocyte death 
following SCI remains unclear. Here we report that mRNAs extracted 15 min, 4 hr, 1 day, or 1 
month after cervical SCI show marked upregulation of sPLA2-IIA and IIE at 4 hr after injury. In 
contrast, SCI induced down regulation of sPLA2-X, and no change in sPLA2-IB, IIC, V, and XIIA 
expression. At the lesion site, sPLA2-IIA and IIE expression were localized to oligodendrocytes. 
Recombinant human sPLA2-IIA (0.01, 0.1, or 2 μM) induced a dose-dependent cytotoxicity in 
differentiated adult oligodendrocyte precursor cells but not primary astrocytes or Schwann cells in 
vitro. Most importantly, pretreatment with S3319, a sPLA2-IIA inhibitor, before a 30 min H2O2 
injury (1 or 10 mM) significantly reduced oligodendrocyte cell death at 48 hr. Similarly, 
pretreatment with S3319 before injury with IL-1β and TNFα prevented cell death and loss of 
oligodendrocyte processes at 72 hr. Collectively, these findings suggest that sPLA2-IIA and IIE 
are increased following SCI, that increased sPLA2-IIA can be cytotoxic to oligodendrocytes, and 
that in vitro blockade of sPLA2 can create sparing of oligodendrocytes in two distinct injury 
models. Therefore sPLA2-IIA may be an important mediator of oligodendrocyte death and a novel 
target for therapeutic intervention following SCI.
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INTRODUCTION
Spinal cord injury (SCI) results from an initial mechanical damage to the cord tissue 
followed by a cascade of “secondary injury”, leading to widespread neuronal and glial cell 
death as well as demyelination (Cao et al. 2005b; McTigue et al. 2001; Totoiu and Keirstead 
2005). Notably, oligodendrocytes are particularly sensitive to apoptosis during secondary 
injury, which results in a loss of myelin around surviving axons peripheral to the lesion 
epicenter (Blight 1985; Crowe et al. 1997; Totoiu and Keirstead 2005). By seven days post 
injury, 93% of the oligodendrocytes at the impact site are lost (McTigue et al., 2001). 
Therefore, therapeutic manipulation of oligodendrocyte survival after neurotrauma 
represents a viable approach to restore functional conduction of intact but demyelinated 
axons.
To date, many mediators of secondary injury have been suggested such as free radicals (Liu 
et al. 2004a; Park et al. 2004) and cytokines including TNFα an IL-1β (Demjen et al. 2004; 
Hostettler and Carlson 2002; Wang et al. 2006). Previously we proposed that phospholipases 
A2 (PLA2) might function as both a secondary mediator of SCI as well as a convergence 
molecule that mediates the cytotoxicity of other injurious agents (Liu et al. 2006). Since the 
CNS is predominantly composed of lipids and 44% exclusively phospholipids, it could be 
particularly susceptible to phospholipases A2 (Morell 1984). PLA2 are a group of enzymes 
that hydrolyze the ester bond at the sn-2 position of membrane phospholipids producing a 
free fatty acid, such as arachidonic acid (AA), and a lyso-phospholipid, such as lysolechithin 
(a.k.a lysophosphatidyl choline, L-PC).
Our previous work demonstrated that both total PLA2 activity and cPLA2α (PLA2-IVα) 
protein expression increased following SCI (Liu et al. 2006). However, total PLA2 activity 
peaked at 4 hr while cPLA2α (PLA2-IVα) protein did not significantly increase until 7 days 
post injury. This paradox suggests that another isoform of PLA2 might be responsible for the 
increase in total phospholipases activity after SCI. The PLA2 isoforms are divided into 
either secreted (sPLA2), Ca2+-dependent cytosolic (cPLA2; group IV), or Ca2+-independent 
cytosolic (iPLA2; group VI) (Six and Dennis 2000). To date, eleven mammalian sPLA2s, 
i.e., groups IB, IIA, IIC, IID, IIE, IIF, III, V, X, XII, and XIII, have been identified. 
Normally, many of the sPLA2s are present in the mammalian brain (Kolko et al. 2006; 
Molloy et al. 1998) and spinal cord at low levels (Svensson et al. 2005). More clinically 
relevant, sPLA2 has recently immerged as a mediating factor in cerebral ischemia and 
neuronal apoptosis (Adibhatla and Hatcher 2007; Estevez and Phillis 1997; Lin et al. 2004; 
Yagami et al. 2002). However, any role that sPLA2 might play in oligodendrocyte death 
following neurotrauma is unknown.
One rational for investigating sPLA2’s role in SCI-induced oligodendrocyte death is that 
many mediators of secondary SCI are both activators of sPLA2 and cytotoxic to 
oligodendrocytes. For example, hydrogen peroxide injury triggers phospholipid metabolism 
and AA release in various cell types (Cane et al. 1998; Meyer et al. 1996; Tournier et al. 
1997) and H2O2 induced AA release is mediated, at least in part, by sPLA2-IIA (Han et al. 
2003). Likewise, IL-1β and TNFα trigger AA release from cultured cells via a sPLA2-IIA 
and cPLA2-IVα dependent mechanism (Kuwata et al. 2005; Mounier et al. 2004). Finally 
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H2O2 (Mronga et al. 2004; Richter-Landsberg and Vollgraf 1998), IL-1β (Takahashi et al. 
2003), TNFα (Lee et al. 2000; Selmaj and Raine 1988), and AA (Wang et al. 2004) have all 
been shown to damage cultured oligodendrocytes.
Until now, the expression of sPLA2 isoforms after SCI and their possible role in 
oligodendrocyte death has not been directly studied. Here we provide cellular and molecular 
evidence that sPLA2-IIA and IIE are the two major sPLA2 isoforms that are induced in the 
hours following SCI and that both isoforms are present within oligodendrocytes. Moreover, 
exogenous administration of sPLA2-IIA in vitro can induce oligodendrocyte cell death but 
has no affect on astrocytes or Schwann cells. Finally, blockade of sPLA2 can partially 
ameliorate cultured oligodendrocyte cell death induced by either H2O2 or IL-1β and TNFα 
injury. Thus, sPLA2-IIA may serve as a mediator of oligodendrocyte death and a target for 
therapeutic intervention against injury-induced oligodendrocyte cell death following SCI.
MATERIALS AND METHODS
Animals
A total of 82 female Sprague–Dawley rats (Harlan, Indianapolis, IN), 200 to 220 g, were 
used (Table 1). All surgeries and animal care were performed in accordance with the Guide 
for the Care and Use of Laboratory Animals and the Guidelines of the University of 
Louisville Institutional Animal Care and Use Committee.
Spinal Cord Injury
Rats were anesthetized with sodium pentobarbital (50 mg/kg), given preoperative 
gentamicin (5 mg/kg, s.c.), 5 ml of normal saline, and placed on a homeothermic blanket. 
Skin was incised and the underlying muscles were dissected to expose the C2-C7 vertebrae. 
The exposed vertebral column was stabilized using bilateral transverse supports placed 
underneath the spinal column which were developed at the University of Louisville (Cao et 
al. 2005b; Liu et al. 2007; Zhang et al. 2004). A dorsal laminectomy was performed at the 
C4-5 level to expose the spinal cord. The body was immobilized with a horizontal brace 
gently secured over the middle of the back to prevent it from moving upward during the 
SCI. Rats received either a 200 kDyn injury (measured force = 210±7 kDyn, Cv = 3.28%) 
inflicted via an Infinite Horizons (IH) impactor with an enlarged head (3.4 mm vs. 2.5 mm), 
or sham laminectomy (Onifer et al. 2007; Scheff et al. 2003). Displacements were measured 
to insure lesion uniformity (1086±93 μm; Cv = 8.56%). Muscle and skin incisions were 
closed with silk sutures and wound clips, respectively. Histological quantification of the 
injury is provided in Sup.1 using methods previously described (Titsworth et al. 2007).
Special post-operative care was given as previously described (Onifer et al. 2007). Briefly, 
injured rats were universally quadriplegic but showed no signs of respiratory distress. Each 
rat was returned to its cage with clean bedding. Half of the cage was placed on a water 
circulating heating pad for 24 hr. Water bottles with straight spouts were used and standard 
rat chow, rat chow softened with water, and ENSURE® were placed on the bedding when 
necessary. The state of hydration and gastrointestinal function were monitored daily. 
Bladders were manually voided twice daily until bladder function returned. Breathing was 
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monitored every 10 min for the first hr, every hr for the first 12 hrs, and twice daily 
thereafter. Antibiotics were injected at 2 day intervals for 6 days. The wound clips were 
removed 7–10 days post surgery.
RNA Extraction and RT-PCR
A 1.5 cm long spinal cord segment containing the injury epicenter or equivalent (shams) was 
removed 4 hr post injury, frozen in liquid nitrogen, and later homogenized in STAT-60 
solution (TelTest, Friendswood, TX) according to the manufacturer’s instructions. Purify 
RNA was quantified by spectrophotometric analysis at 260 nm. Primers used for end point 
RT-PCR are listed in Table 2.
Primers for sPLA2-IID, IIF, and XIIA were designed using Primer Express 2.0 (Applied 
Biosystems, Foster City, CA). Each primer set was validitated in mRNA extracted from the 
liver, lung, kidney, or spleen. Total RNA (0.5 μg) was used in a 20 μl mixture containing 4 
μl of 5× reaction buffer, 0.2 mM dNTP, 1 μM of up and down stream primer, 1 mM MgSO4, 
0.1 u/μl AMV Reverse Transcriptase, and 0.1 u/μl Tfl DNA Polymerase. The reverse 
transcription was conducted with a 45 min first strand cDNA synthesis (45 °C), 2 min 
denaturation (94 °C), followed by 35 cycles of synthesis and amplification consisting of 30 
seconds (94 °C), 1 minute (60 °C), and 2 minutes (72 °C) (Access RT-PCR system, 
Promega, Madison, WI). Amplified samples were separated on a 1% agarose gel containing 
ethidium bromide in 1× TBE buffer. After electrophoresis, gels were imaged using an Image 
Station 4000R (Kodak, Rochester, NY).
Real-Time Quantitative PCR
Total RNA was extracted 4 hr after sham operation or 15 min, 1 hr, 4 hr, 1 day, or 1 week 
after SCI. Primers and a taqman probe for sPLA2-IIA were designed using Primer Express 
2.0 and are as follows: IIA sense 5′-CCAAATCTCCTGCTCTACAAACC-3′, IIA antisense 
5′-CTTTTCTTGTTCCGGGCAAAAC-3′, and IIA probe 5′-
CGGCAGCTTTATCGCACTGGCACA-3′. MX3000P (Stratagene, La Jolla, CA) calculated 
the threshold cycle number (Ct) as ten-fold the standard deviation of the baseline. Primer 
pairs were chosen to minimize primer dimerization and secondary structure; and to generate 
an amplicon of 96 bp. To correct for volume differences and cap transparency the passive 
reference dye 5(6)-carboxy-X-rhodamine-C5-maleimide (Stratagene) was used. After a 3 
min denaturation step, the samples were subjected to 40 cycles of 30 sec annealing and 30 
sec extension at 72 °C. Relative expression of the PCR products was determined by using 
the ΔΔCt method (Gibson et al. 1996). Each sample was run in duplicate, and the mean Ct 
was used in the ΔΔCt equation. After PCR, reaction products were electrophoresed as before 
to ensure that the PCR product was the desired amplicon size.
Western Blotting
Western blotting followed a previously described procedure (Liu et al. 2007). In brief, whole 
cell lysis proteins were extracted from a 1.5 cm long spinal cord segment containing the 
injury epicenter 4 hr after sham laminectomy or 15 min, 4 hr, 1 day or 1 week after SCI. 
Additionally, subcellular protein isolation was performed on either sham animals or 4 hr 
after injury using the Focus SubCell kit (G-Biosciences, St. Louis, MO) according to 
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manufacturer’s protocol. In brief, 100 mg of fresh tissue was homogenized and centrifuge at 
700 × g for 5 minutes to pelletise nuclei. Supernatant was removed and centrifuged at 
12,000 × g for 10 min to pelletise mitochondria. Supernatant was again removed and 
centrifuged at 14,000 × g for 60min to separate the enriched cytosolic membrane fraction 
from the soluble cytosol fraction. The protein content of all samples was assessed by the 
Bradford method (Bio-Rad Protein Assay, Hercules, CA) and normalized prior to adding 
sample buffer.
Similar amounts of protein (40 μg) was electrophoresed on a 12% SDS-polyacrylamide gel 
and immunoblotted with primary rabbit monoclonal anti-sPLA2-I antibody (1:100; “Anti-
PLA2, low molecular weight” Millipore, Billerica, MA), polyclonal anti–sPLA2-IIA 
antibody (1:1000; Cayman Chemical, Ann Arbor, MI), polyclonal anti-sPLA2-IIE antibody 
(1:1000; Biovendor, Candler, NC), or goat polyclonal anti-sPLA2-X antibody (1:200; Santa 
Cruz Biotechnology, Santa Cruz, CA) and a secondary horseradish peroxidase–conjugated 
donkey anti–rabbit or anti-goat IgG antibody (1:10,000; Amersham Pharmacia Biotech, 
Piscataway, NJ). Whole cell lysis membranes were stripped and reblotted with anti-β-tubulin 
(mouse monoclonal antibody, 1:1000, Sigma, St. Louis, MO). Subcellular fraction 
membranes were stripped and reblotted with anti-β-tubulin, caveolin (rabbit polyclonal 
antibody 1:100, Santa Cruz), or histone H1 (rabbit polyclonal antibody, 1:200, Santa Cruz) 
for the cytosol, membrane, and nuclear fractions respectively. The primary antibody was 
omitted for negative controls. Splenic protein served as positive control for sPLA2-IIA. 
Densitometry allowed for relative comparison of signal strength by Image J software.
Immunohistochemistry
Spinal cords were removed 4 hrs after sham operation or 15 min, 1 hr, or 4 hr after SCI. 
After perfusion with PBS and 4% paraformaldehyde, a 2 cm-long spinal cord segment 
containing the injury epicenter of each rat was removed, cryoprotected in 30% sucrose 
buffer, sectioned transversely at 40 μm, and mounted on charged slides in eight identical 
sets. Three sections were taken from each of five sample sites within the tissue, every 0.5cm, 
and were incubated with either anti-sPLA2-IB (1:200), anti-sPLA2-IIA (1:300), anti-sPLA2-
IIE (1:200), or anti-sPLA2-X antibody (1:200) overnight at 4°C and subsequently with 
secondary biotinylated IgG antibody (1:400; Vector Laboratories, Burlingame, CA) for 1 hr 
at room temperature. The reaction product was shown by incubation with 0.02% 
diaminobenzidine tetrahydrochloride (DAB) and 0.003% H2O2 in 0.05M Tris-HCl. 
Negative controls of pooled normal antibodies (Vector Laboratories) were used 
simultaneously.
Using standard light and aperture settings, images were captured at 2 × and staining 
intensities were determined using Image J software (NIH) by first inverting the image and 
then measuring the mean intensity. The intensity of the negative control animal was 
subtracted from the recorded intensities to account for unintentional secondary antibody 
binding and natural tissue coloration.
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Immunofluorescence Labeling
Immunofluorescence double labeling at the injury epicenter was performed on different 
tissue sets using previously described methods (Liu et al. 2004b). A mixture of anti-sPLA2-
IB (1:100), anti-sPLA2-IIA (1:100), anti-sPLA2-IIE (1:50), or anti-sPLA2-X antibody 
(1:50), and mouse anti-CC1 (1;100; Chemicon), anti–glial fibrillary acidic protein (1:300; 
Sigma), and anti-O4 (1:1; hybridoma), anti-NeuN (1:100; Chemicon, Temecula, CA), and 
anti-SMI-31 (1:2,000; Sigma) antibodies were used to examine neurons, axons, 
oligodendrocytes, or astrocytes in vivo or mature oligodendrocytes in vitro respectively. The 
following day, sections were incubated with fluorescein-conjugated goat anti–mouse (1:100) 
and Texas red-conjugated goat anti–rabbit antibodies (1:100; Jackson Immunoresearch; 
West Grove, PA). Controls were similar to immunohistochemistry. Images were taken using 
a Nikon Eclipse 90i confocal microscopy (Nikon Instruments; Melville, NY).
sPLA2-IIA signal within oligodendrocytes was quantified using StereoInvestigator software 
(Microbrightfield,Williston, VT) under 100× oil immersion. Under standard exposure times 
contour tracing was begun around the cells of interest while viewed through an FITC filter. 
After switching to Texas Red filter, luminescence data was acquired for the cell of interest 
by closing the contour. Twenty oligodendrocytes were chosen from each of three different 
tissue sections, by systematic random sampling from the ventral funiculus of the lesion 
epicenter. The intensities of these cells were averaged to create mean florescence for 
oligodendrocytes in each animal (n=5, per group). Background intensity was gathered in a 
similar manner from primary antibody omission control section and subtracted from the 
mean intensity for that given animal. This was done to control for non-specific binding of 
secondary antibody following contusion.
Cell Culture
Adult oligodendrocyte precursor cells (aOPCs) were obtained from adult rat spinal cords 
using protocols modified from (Cao et al. 2002). Minced spinal cords were incubated in 
HBSS containing 0.1% papain, 0.1% neutral protease, and 0.01% DNase. Following the 
addition of DMEM containing 10% fetal bovine serum (FBS) tissues were dissociated and 
incubated on an anti-RAN-2 antibody (ATCC, Rockville, MA) coated dish to deplete type-1 
astrocytes and meningeal cells and then an anti-O4 antibody-coated dish to select for adult 
OPCs. The purified aOPCs were cultured in DMEM/F12 medium containing N2 and B27 
supplements, FGF2 (20 ng/ml), PDGF-aa (10 ng/ml), Insulin (5 μg/ml) and BSA (0.1%). 
Only those cell preparations in which >95% A2B5+ cells were used.
The cells were seeded onto either PDL/laminin coated culture dishes or chamber slides. Two 
days after seeding or once cells reached 70-80% confluence, the FGF-2 and PDGF-aa were 
removed, and CNTF (0.001 μg/ml) was added to the OPC medium to induce differentiation. 
aOPCs were induced to differentiate in vitro for 4 days prior to use.
The procedures for Schwann cell preparation and purification have been extensively used in 
our lab (Xu et al. 1995). Schwann cells were purified from sciatic nerve explants with 10% 
FBS in DMEM. Explants were passaged 5 times and treated with 1.25U/ml dispase 
(Boehringer Mannheim Biochemicals, Indapapolis, IN), 0.05% collagenase (Worthington 
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Biochemical Corp., Freehold, NJ), and 15% FBS in DMEM. Explants were dissociated, 
plated onto poly-L-lysine coated dishes, and treated with 20 μg/ml pituitary extract (BTI, 
Stoughton, MA) and 2 mM forskolin (Sigma). When SC’s reached confluence they were 
treated with Ca2+ and Mg2+ free HBSS and briefly treated with 0.05% trypsin (Gibco) and 
0.02% EDTA (Gibso) for passage and were plated in a 96-well plate at a density of 4×104 
cell per well. The purity of the SCs was ascertained by s-100 staining.
Astrocytes were isolated from the cerebral cortices of postnatal 2 to 3 day old SD rat pups. 
Minced cortices were incubated in DMEM with 0.25% (w/v) trypsin-EDTA at 37 °C for 7 
min. The suspension was filtered and centrifuged at 1000 rpm for 5 min. The cell pellet was 
re-suspended in DMEM plus 10% (v/v) FBS, 100 IU/mL penicillin, 100 μg/mL 
streptomycin, and transferred to T75 culture flasks. The medium was changed twice a week 
until cells reached approximately 80–90% confluence, flasks were shaken at 170 rpm for 16 
h at 37 °C to remove microglia. Then, cells were removed from the flasks by 0.05% (w/v) 
trypsin-EDTA treatment, and seeded at 1×104 cells per well in 96 well culture dishes. 
Astrocytes were identified by GFAP staining with purity > 95% in all cultures.
Schwann cell, astrocytes, and mature oligodendrocyte cultures were injured with 
recombinant human sPLA2-IIA (Biovendor, Candler, NC) and assayed at 48 hr. Cytotoxicity 
was measured by measuring lactate dehydrogenase (LDH) in the medium (CytoTox96 
assay; Promega, Madison, WI). Data were normalized to the amount of LDH released from 
similarly-treated cells lysed with 9% Triton X-100 and are corrected for background from 
wells lacking cells. Cell viability was assessed by reduction of (3-(4,5-Dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide by the mitochondria of surviving cells (MTT, CellTiter 
96 Cell Proliferation Assay; Promega). Control wells were run in each plate to ensure that 
measurements fell within test sensitivity.
It has been previously shown that the commercially available, small (487.63 MW), 
lipophilic molecule 5-(4-Benzyloxyphenyl)-4S-(7-phenylheptanoylamino) pentanoic acid 
(henceforth referred to as S3319; Sigma) inhibits sPLA2-IIA in vitro using a standard 
enzyme assay (IC50 = 0.029 μm, 0.000019 mole fraction; compound 2b in (Hansford et al. 
2003). Therefore, a second set of cultures were pretreated with vehicle, or 0.25, 1.25, 6.25 
μM of S3319, a sPLA2-IIA inhibitor diluted in 1% DMSO (Sigma). Then cells were 
challenged with vehicle, 1mM, 5 mM, or 10mM H2O2, with or without sPLA2-IIA inhibitor 
for 30min, washed once with fresh medium, and the vehicle or S3319 was replaced. Again 
cytotoxicity was evaluated by measuring LDH released.
A third set of cultures were pretreated as above with S3319 but were challenged with the 
cytokines IL-1β (PeproTech Inc., Rocky Hill, NJ) and TNFα (PeproTech) at low (1 and 2 ng 
respectively) or high dose (5 and 10 ng). Again cytotoxicity was evaluated by LDH released. 
All cell culture experiments consisted of 4-6 separate wells and were repeated in triplicate 
on separate days. The results presented are the averaged of the three separate experiments. 
The area of process extensions was calculated using three separate images take from the 
center of each well. Images were converted to binary by setting a common constant 
threshold and then the area was determined by Image J software.
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Statistical Analysis
One-way analysis of variance (ANOVA) with post hoc Tukey HSD was used to determine 
statistical significance of three or more groups. A multiple analysis of variance (MANOVA) 
with post hoc Tukey HSD was used to determine statistical significance of three or more 
groups when repeated measures were taken from each animal overtime or space. Two 
extreme outliers were excluded from the Q-PCR data using the Grubb’s extreme studentized 
deviate method.
RESULTS
sPLA2 mRNAs are differentially expressed following SCI
End point RT-PCR was used to scan for the expression of all the sequenced mammalian 
sPLA2 isoforms in sham and contused animals 4 hr following surgery (n = 3). Of the nine 
mammalian sPLA2 isoforms, seven were detected in naïve and contused animals (sPLA2-IB, 
IIA, IIC, IIE, V, X, and XIIA; Fig. 1A). Among all sPLA2 isoforms examined, sPLA2-IIA 
showed the most dramatic change after SCI (Fig. 1A). Similarly, sPLA2-IIE showed an 
increase in the injured cord. In contrast, PLA2-X showed a decrease in signal intensity (Fig. 
1A). sPLA2-IB, IIC, V and XIIA were present in both the sham and contused cord in similar 
amounts.
Next, real-time Q-PCR was used to quantify the increase seen after RT-PCR and determine 
the time course of sPLA2-IIA expression following SCI. sPLA2-IIA was chosen because of 
its significant association with inflammation (Kolko et al. 2004) and is quantified as a fold 
increase from naïve animals (Fig. 1B). In agreement with the RT-PCR results, sPLA2-IIA 
mRNA expression had a significant 4-fold increase at 1hr following contusion and remained 
elevated at 4 hr (ANOVA, F6, 30 = 4.313, p = 0.0012).
sPLA2 proteins are differentially expressed following SCI
To confirm that mRNA changes corresponded to changes in protein production, spinal cord 
homogenates were immunoblotted with antibodies to sPLA2-IB, IIA, IIE, or X. While a 
general increase in the mean expression of sPLA2-IB was seen, this was not statistically 
significant further confirming the PCR results (Fig. 2A & B; ANOVA, F4,15 = 0.8335, p = 
0.52). In contrast, sPLA2-IIA showed a 3-fold increase in protein expression at 4 hr 
compared to sham controls (Fig. 2A & C, ANOVA, F4,15 = 4.860, p < 0.01). Significantly 
increased sPLA2-IIA expression was also found at both 4 hr and 1day post injury (Fig. 2C). 
An equal amount of splenic protein was run as a positive control for sPLA2-IIA and showed 
a band about 3.6 times greater than the strongest spinal cord band, confirming the lower 
abundance in the spinal cord as compared to the spleen (Fig. 2A, lane 6 of IIA blot). Not 
surprisingly, sPLA2-IIE showed similar results to IIA with a significant 2.5 fold-increase 
that peaked at 4 hr after SCI and returned to the baseline by 1 day (Fig. 2A & D, ANOVA, 
F4,15 = 5.025, p < 0.01). Finally, while sPLA2-X mRNA decreased following SCI there was 
little change in the protein levels compared to the sham controls (Fig. 2A & E, ANOVA, 
F4,15 = 0.2554, p = 0.90). Interestingly, the peak expression of the two sPLA2 isoforms 
coincides well with the peak activation of total PLA2, as we demonstrated previously (Liu et 
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al. 2006). Thus, sPLA2-IIA and IIE may represent major contributors to phospholipase 
activity following SCI.
Spatiotemporal distribution of sPLA2 isozymes following SCI
Since sPLA2 mRNA and proteins were differentially expressed post SCI, we next 
determined their temporal and spatial distribution using immunohistochemistry. In this 
study, sPLA2-IB, IIA, IIE, and X were examined at 5 mm intervals from the injury 
epicenter. Initial examination of whole spinal cord sections reveals significantly more 
immunoreactivity of IIA (Fig. 3B & F) and IIE (Fig. 3C & G) in the contused animals with 
little change in either IB or X isoforms (Fig. 3A, E, D & H). Quantification of staining 
intensity using Image J showed no change in sPLA2-IB signaling either among different 
time points post SCI or distance from the epicenter (MANOVA F3, 263.806 = 4.367, p > 0.05, 
Fig. 3I). However, a significant increase in sPLA2-IIA immunoreactivity was observed at 
the injury epicenter in all SCI groups over sham controls (MANOVA F18.3, 15.575 = 46.437, 
p < 0.001, Fig. 3J).
We chose to focus on white matter because previous results indicate that bilateral injections 
of sPLA2-III (0.1 μg) into the ventral grey matter/white matter interface of rat spinal cords 
resulted in a massive destruction of white matter with a relative sparing of grey matter at 4 
weeks (Sup. 2)(Liu et al. 2006). Within the white matter sPLA2-IB showed strong 
expression both before and after injury (Fig. 3K & O). In contrast, sPLA2-IIA and IIE each 
showed a weak baseline staining in the white matter of sham controls (Fig. 3L & M 
respectively). However, following SCI, sPLA2-IIA and IIE immunoreactivity increased 
markedly (Fig. 3P & Q). Finally, sPLA2-X showed little immunoreactivity either in sham or 
SCI animals (Fig. 3N & R). Based solely on morphology it appears that within the white 
matter, a strong increase in sPLA2-IIA and IIE staining in glial cells and axons, particularly 
swollen axons, was seen (Fig. 3P, arrows). Subsequently these observations were confirmed 
with immunofluorescent double labeling of axons (SMI-31+), astrocytes (GFAP+), and 
neurons (NeuN+) and are provided in the Supplemental Figures 3-5. It should be noted that 
IIA and IIE are structurally and functionally similar and are both located at the same genetic 
locus (Kudo and Murakami 2002).
Cellular localization of sPLA2 isozymes following SCI
To better characterize what cell types express sPLA2 isoforms, immunofluorescent double 
labeling of sPLA2–IB, IIA, IIE, or X and cell specific markers was performed. As was 
suggested by the immunohistochemistry, we found that oligodendrocytes (CC1/APC; Fig. 4) 
co-localized with sPLA2-IB (Fig. 4B & C), sPLA2-IIA (Fig. 4E & F), and sPLA2-IIE (Fig. 
4H & I). However, sPLA2-X did not appear to co-localize with oligodendrocytes (Fig. 4J-L). 
The sPLA2-X staining appeared to reside only in the extracellular space. This morphology is 
not surprising since sPLA2-X has the greatest secreted fraction and the lowest cytosolic 
fraction of any sPLA2 (Murakami et al. 2002). Additionally, previous work with stably 
transfected cell lines yielded similar sPLA2-X immunofluorescence (Kudo and Murakami 
2002).
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Within the white matter, astrocytes (GFAP; Sup. 3) co-localized with sPLA2-IB (Sup. 3B & 
C) and weakly with sPLA2-IIA (Sup. 3E & F) but showed no co-localization with sPLA2-
IIE (Sup. 3H & I) or with sPLA2-X (Sup. 3J-L). Neurons within the ventral grey matter 
(NeuN; Sup. 4), showed similar staining to oligodendrocytes with the presence of sPLA2-IB 
(Sup. 4B & C), sPLA2-IIA (Sup. 4E & F), and sPLA2-IIE (Sup. 4H & I), but not sPLA2-X 
(Sup. 4K & L). Almost all axons (SMI-31; Sup. 5) within the ventral white matter showed 
co-localization with sPLA2-IB (Sup. 5B & C) and sPLA2-IIA (Sup. 5E & F). sPLA2-IIE 
staining was weak and confined mainly in axons that appeared to be swollen (Sup. 5H & I, 
arrows) and no axons appeared to co-localize with sPLA2-X (Sup. 5K & L).
To further confirm that sPLA2-IIA was not merely present in oligodendrocytes but increases 
following contusion, we compared sPLA2-IIA labeling intensities within oligodendrocytes 
at the injury epicenter 4 hr after either sham surgery (Fig. 5A-C) or SCI (Fig. 5D-F). A 
significant increase in sPLA2-IIA expression was found within oligodendrocytes (t(5.947) = 
−3.517, p = 0.01, Fig. 5G). Increased expression of sPLA2s, particularly IIA, opens a new 
possibility that it may play a role in the death of oligodendrocytes following SCI.
sPLA2-IIA increases in membrane fraction following SCI
sPLA2-IIA could only increased phospholipid hydrolysis following SCI if it co-localized 
with its phospholipid substrate, which is most abundant in the membrane fraction of cells. 
Therefore subcellular fractions of sham and contused spinal cords were immunoblotted for 
sPLA2-IIA expression. Four hours following contusion, sPLA2-IIA increased about 4-fold 
within the membrane fraction of the cytosol (Fig. 5H). While the non-membrane fraction of 
the cytosol did show a strong band for sPLA2-IIA there was little increase following 
contusion. Additionally, the nuclear fraction showed no sPLA2-IIA expression. The purity 
of subcellular fractions was confirmed by separate blotting for caveolin, histone H1, and β-
tubulin (Fig. 5I). These results suggest that the increase in sPLA2-IIA protein expression 
observed in the whole cell lysates after SCI is within the membrane fraction which is rich in 
phospholipid substrates suggesting a functional role sPLA2-IIA on its phospholipid 
substrates.
sPLA2-IIA induces oligodendrocyte death in vitro
We next examined what effect increased sPLA2-IIA might have on oligodendrocytes 
directly. These studies focused on oligodendrocytes for two reasons. First, whereas sPLA2-
IIA induced neuronal apoptosis has already been shown (DeCoster 2003; Yagami et al. 
2002; Yagami et al. 2003), the role of sPLA2-IIA in oligodendrocyte cell death remains 
unexamined. Secondly, our previous observation indicates that sPLA2 is potentially more 
destructive to white matter than grey matter (Sup. 2).
To determine whether sPLA2-IIA can directly affect oligodendrocyte viability, recombinant 
human sPLA2-IIA was added to differentiated aOPC, astrocytes, and Schwann cells. In 
oligodendrocytes sPLA2-IIA triggered a dose-dependent increase in LDH corresponding to 
an increase of cell cytotoxicity from 16.0 ± 5.3 % in control wells to 34.3 ± 6.3 % in wells 
treated with 2 μM of sPLA2-IIA at 48 hr (F3,16 = 13.04, p < 0.001; Fig. 6E). Similarly, the 
MTT assay showed a corresponding change with control wells showing an optical density 
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(OD) of 0.040 ± 0.005 and the 2 μM sPLA2-IIA dose resulting in an OD of 0.027 ± 0.005 
(F3,16 = 13.04, p < 0.001; Fig. 6F). Phase contrast images of these wells confirmed 
oligodendrocyte damage with a decreased arbor in the 0.01 and 0.1 μM concentrations and a 
complete degradation of the cell soma and processes at the 2μM concentration (Fig. 6A-D).
To determine the relative specificity of sPLA2-IIA’s effect on oligodendrocytes, identical 
concentrations were added to primary astrocytes and Schwann cells cultures. Interestingly, 
no cell death was noted in either culture suggesting that sPLA2-IIA has little effect on 
astrocytes (another CNS glia) or Schwann cells (PNS glia). These findings might explain 
why sPLA2 injections into the spinal cord white matter result in oligodendrocyte death but 
showed strong gliosis and delayed remyelination of spared axons by Schwann cells 
(Titsworth et al. 2007). Since sPLA2-IIA administration can induce oligodendrocyte and 
neuron death in vitro, blocking sPLA2-IIA expression or activity may prevent such cell 
death following injury.
sPLA2 inhibition attenuates H2O2 induced oligodendrocyte death in vitro
To address what effects injury induced sPLA2-IIA expression might have on 
oligodendrocytes, an in vitro Hydrogen peroxide (H2O2) injury model was developed. When 
aOPC were challenged with a 30 min pulse of H2O2, there was a dose dependent increase in 
sPLA2-IIA expression over the vehicle control 48 hr after H2O2 insult (Fig. 7A). 
Immunoflorescence staining confirmed the presence of sPLA2-IIA in oligodendrocytes in 
naïve cultures (Fig. 7B-D) and following H2O2 treatment (Fig. 7E-J). Interestingly, sPLA2-
IIA staining in naïve oligodendrocytes was homogenously distributed (Fig. 7D insert) 
whereas in H2O2 treated cells sPLA2 aggregated into perinuclear puncta (Fig. 7G & J 
inserts). It should be noted that the cells showing sPLA2-IIA aggregation also show nuclear 
fragmentation stained by Hoechst 33342, a nuclear dye suggesting apoptosis (Fig. 7G&J 
inserts, blue).
Next, differentiated oligodendrocyte cultures were challenged with either 1 mM or 10 mM 
H2O2 for 30 min after the administration of various doses of S3319, a small molecule 
inhibitor designed to block the sPLA2-IIA enzymatic site. Forty-eight hours following H2O2 
injury, wells containing the sPLA2-IIA inhibitor S3319 showed reduced cytotoxicity in both 
H2O2 injury intensities (MANOVA F3,48 = 26.63, p < 0.0001; Fig. 8). In the 10 mM H2O2 
treated wells; cells treated with vehicle showed LDH levels suggestive of 46.3 ± 9% cell 
death as compared to 28.4 ± 3% cell death in the S3319 treated wells (p < 0.001). These 
results suggest that increased sPLA2-IIA enzymatic activity partially mediates H2O2 induced 
oligodendrocyte cell death.
sPLA2 mediates IL-1β and TNFα induced oligodendrocyte injury in vitro
To investigate whether the beneficial effects of sPLA2 blockade mediate more than H2O2 
induced oligodendrocyte injury, we developed a cytokine injury model for oligodendrocyte. 
IL-1β and TNFα were chosen because both are suggested mediators of secondary SCI 
(Demjen et al. 2004; Hostettler and Carlson 2002) and exogenous IL-1β and TNFα induces 
sPLA2-IIA dependent AA release in many cell lines (Kuwata et al. 1998; Kuwata et al. 
2005; Kuwata et al. 2000). Similarly, we found that treatment with IL-1β and TNFα created 
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a time dependent increase in sPLA2-IIA expression in cultured oligodendrocytes (Fig. 9A). 
When high doses of IL-1β and TNFα were added pretreatment with S3319 showed a 
decrease in cytotoxicity, as measured by LDH release after treatment (MANOVA F1,30 = 
16.85, p < 0.0001; Fig. 9H). More dramatic than the observed sparing was the 
morphological changes associated with this injury model. IL-1β and TNFα treatment results 
in a dramatic decrease in oligodendrocyte processes extending from the soma at 48 hr (Fig. 
9B-D). Interestingly, this process loss was similar to that observed following addition of 
0.01 and 0.1 μM of sPLA2-IIA to oligodendrocyte cultures (Fig. 6B & C). When cultures 
were pretreated with S3319, this loss of oligodendrocyte processes was almost fully 
prevented (Fig. 9E-G). Quantification of area covered by oligodendrocyte processes 
confirms this observation (MANOVA F1,30 = 9.27, p < 0.01, Fig. 9I).
DISCUSSION
sPLA2 expression following SCI
We previously showed that cPLA2-IVα (cPLA2α) protein expression increased following 
SCI and peaked at 7 days post injury. However, measurements of total PLA2 enzymatic 
activity in spinal cord homogenates peaked much earlier, at 4 hr (Liu et al. 2006). This led 
us to believe that some other PLA2 isozyme contributed to the increase in phospholipases 
activity observed following SCI. We found that of the seven sPLA2 isoforms expressing 
mRNA, two were up regulated (IIA and IIE). These results were further confirmed at the 
protein level with a peak expression at 4 hr which coincides with both apoptosis following 
SCI (Liu et al. 1997) and the time of peak phospholipase A2 activity following SCI (Liu et 
al. 2006).
The presence of sPLA2-IB, IIA, IIC, IIE, V, and X within the mammalian brain is well 
established (Kolko et al. 2004; Molloy et al. 1998; Suzuki et al. 2000). However, only 
sPLA2-IIA and V protein expression has been investigated in the spinal cord and no study 
has looked at the effect of neurotrauma on sPLA2 expression (Svensson et al. 2005). 
Interestingly, sPLA2-IB has been shown to increase following KA injection and 
electroconvulsive shock (Kolko et al. 2005); IB, V, and X increased after retinal damage 
(Kolko et al. 2004); and IIA increased following cerebral ischemia (Adibhatla and Hatcher 
2007; Lin et al. 2004; Yagami et al. 2002). In comparison, this study found that only the 
group II enzymes increased following neurotrauma. Consistent with this tight regulation, the 
promoter region of sPLA2-IIA gene contains TATA and CAAT boxes as well as several 
elements homologous with consensus sequences for binding of transcription factors such as 
AP-1, C/EBPs, CREB, NF-κB, STAT, and PPARγ (Touqui and Alaoui-El-Azher 2001). The 
differential regulation of sPLA2 groups suggests a possible injury and isoform specific 
induction mechanism and varying cellular functions for sPLA2 isoforms in 
neuropathogenesis.
This study also demonstrated an increase of sPLA2 within the membrane fraction of cells 
and a perinuclear compartmentalization of sPLA2-IIA following H2O2 injury. This is 
significant since sPLA2-IIA, while being a secreted molecule, actually displays extremely 
low enzymatic activity toward the phosphatidylcholine-rich external membrane of cells. 
sPLA2-IIA cannot bind to the zwitterionic interface, as a result it shows a marked preference 
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for anionic phospholipids located on the inner leaflet of the bi-lipid membrane (Bezzine et 
al. 2000; Murakami and Kudo 2001). This is supported by the fact that μM levels of 
exogenously added sPLA2-IIA was cytotoxic as opposed to nM levels of sPLA2-III 
(unpublished observation), which shows little preference for anionic phospholipids. Recent 
studies have confirmed that AA release by sPLA2-IIA transfected cells occurs within the 
Golgi compartment following synthesis but prior to its initial secretion to the extracellular 
fluid or binding to anionic heparan sulfate chains on the cell surface (Mounier et al. 2004). 
Therefore, we believe that our observations of increased mRNA levels and increased protein 
within the cytosolic membrane fraction, in conjunction with a perinuclear punctuate 
appearance of sPLA2-IIA following injury indirectly supports the prevailing theory of 
sPLA2-IIA synthesis and activation. However, further enzymatic studies will be needed for 
conclusive confirmation.
sPLA2-IIA’s effect on oligodendrocytes
We next showed that H2O2 or IL-1β and TNFα injuries induce sPLA2-IIA expression in 
cultured oligodendrocytes and that blockade of sPLA2 attenuates H2O2 or IL-1β and TNFα 
induced cell injury. ROS damage is a pervasive injury mechanism involved not only in SCI 
(Liu et al. 2004a; Liu et al. 1999; Park et al. 2004) but also Multiple Sclerosis (Lev et al. 
2006), Alzheimer Disease (Reddy 2006), and Huntington Disease (Rego and Oliveira 2003). 
It was previously shown that H2O2 (Richter-Landsberg and Vollgraf 1998) and AA (Wang 
et al. 2004) can trigger oligodendrocyte death and that H2O2 injury utilizes cPLA2α and 
sPLA2-IIA for AA release in non-CNS cell lines (Han et al. 2003). However, this was the 
first study to demonstrate that blockade of sPLA2-IIA could partially ameliorate the 
cytotoxic effects of H2O2 in oligodendrocytes.
Likewise, IL-1β and TNFα have been known to increase sPLA2-IIA expression and trigger 
AA release from cultured cell lines via sPLA2-IIA and cPLA2-IVα dependent mechanisms 
(Kuwata et al. 2005; Mounier et al. 2004). Additionally these cytokines have been shown to 
damage cultured oligodendrocytes (Lee et al. 2000; Selmaj and Raine 1988; Takahashi et al. 
2003). However, this was the first study to demonstrate that blockade of sPLA2-IIA could 
partially ameliorate the cytotoxicity and morphological damage created by IL-1β and TNFα 
in oligodendrocytes. It must be noted that although S3319 was developed as a specific 
inhibitor of sPLA2-IIA, its activity against other isozymes has not been fully assessed. This 
being said, sPLA2 induction in oligodendrocytes following ROS and cytokine injury could 
be a novel target for therapeutic intervention.
sPLA2-IIA exhibited cytotoxicity at concentrations around 1 μM in cultured 
oligodendrocytes. Does the concentration of endogenous sPLA2-IIA reach such a high level 
in vivo? By comparing the signal intensity of protein extracted from the injured spinal cord 
to purified recombinant human sPLA2-IIA protein we determined that SCI yields roughly 
5×10−3 μg of sPLA2-IIA protein per μg of SCI protein. In comparison we added 4×10−1 μg 
of recombinant human sPLA2-IIA per μg of oligodendrocyte protein in culture to induce 
cytotoxicity. In other words, approximately 80 times more sPLA2-IIA protein was used to 
induce cytotoxicity in vitro than in vivo. This calculation was made on the assumptions that 
the antibody has similar affinity for both rat and recombinant human sPLA2-IIA and that the 
Titsworth et al. Page 13
Glia. Author manuscript; available in PMC 2015 June 10.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
in vivo and in vitro protein extraction methods are comparable. Other authors have found 
that sPLA2-IIA activity induced apoptosis in cultured neurons but only at levels 300 times 
that found in ischemic brain tissue (Yagami et al. 2002). This discrepancy between in vivo 
and in vitro toxicities can be explained by the following reports. First, sPLA2-IIA generated 
from cytokine-stimulated astrocytes might reach to such a high concentration within a 
microenvironment at the cell surfaces via attachment to heparan sulfate proteoglycan 
(Koduri et al., 1998). Second, sPLA2-IIA might cause neuronal and oligodendrocyte cell 
death at lower concentrations in the presence of cofactors (Murakami et al., 1991; Fourcade 
et al., 1995). Third, the sensitivity of the cells to endogenously produced sPLA2-IIA is 
higher than exogenously added sPLA2-IIA due to its intracellular location (Murakami et al., 
1999). The latter seems likely given the preference of sPLA2-IIA for inner leaflet 
phospholipids (Porcellati 1983). It must be noted that the efficacy of S3319, a sPLA2 
inhibitor, in systems with cytokine and peroxide induction of sPLA2-IIA suggests that its 
blockade can crucially affect cytotoxicity despite high levels being need to directly induce 
cytotoxicity.
In this study we chose to focus on the direct cytotoxicity of sPLA2 in isolated 
oligodendrocytes. A second, equally compelling, yet unexplored hypothesis is that sPLA2 
could increase secondary SCI not merely by direct cytotoxicity but also by exacerbating the 
recruitment of neutrophils and macrophages to the injury site which has been previously 
reported (Popovich et al. 1997). Following sPLA2 hydrolysis, phospholipids generate a free 
fatty acid, such as arachidonic acid (AA), and a lysophospholipid such as lysophosphatidyl 
choline (LPC, a.k.a. lysolechithin). AA can later form epoxides via the cytochrome P450 
pathway, leukotrienes via the lipoxygenase pathway, or thromboxanes or prostaglandins via 
the cyclooxygenase pathway. Many of these products, such as prostaglandin E2 (PGE2), can 
subsequently act as potent chemoattractants that increase the endogenous immune response 
(Resnick et al. 2001; Tonai et al. 1999). Furthermore, LPC has been shown to act as a 
proinflammatory chemoattractant for macrophages (Lauber et al. 2003). Therefore, sPLA2-
IIA could directly induce tissue damage as we have shown here or increase inflammation 
following SCI and exacerbate secondary spinal cord injury, a hypothesis that is under 
current investigation.
One assumption made by this work is that SCI results in demyelination and that either 
protection of myelin or de novo production by spared oligodendrocytes could result in 
measurable functional gains. This assumption is based on several observations. First, 
traumatic SCI results in transient post-injury membrane phospholipid hydrolysis (Demediuk 
et al. 1989). Secondly, increased spared white matter correlated with increased functional 
recovery (Rosenberg et al. 1999; Wrathall et al. 1994). Third, transplantation of myelinating 
stem cells results in normal-appearing myelin, recovery of transcranial magnetic motor-
evoked potential responses, and improvements in overground locomotion (Cao et al. 2005a; 
Karimi-Abdolrezaee et al. 2006; Keirstead et al. 2005). Finally, remyelinated axons are 
present from 14 to 450 days post injury but that remyelination was incomplete, as indicated 
by the presence of demyelinated axons at every time point examined (Totoiu and Keirstead 
2005). However, recent studies have brought into question whether chronic demyelination 
persists in functionally intact axons since myelin sheaths not only ensure successful 
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propagation of action potentials, but also participate in axonal transport and survival (Edgar 
and Garbern 2004; Edgar et al. 2004). Lasiene, et al., (2008) used anterograde tracing to 
evaluate the myelin status of functionally intact axons. They showed that virtually no “intact 
axon” remained unmyelinated at 12 weeks in mice suggesting that remyelination or myelin 
sparing strategies may be less promising than originally hypothesized. This hypothesis is 
supported by the fact that remyelination by transplanted cells shows efficacy but only if 
transplants are delivered before 3 weeks (Cao et al. 2005a; Karimi-Abdolrezaee et al. 2006; 
Keirstead et al. 2005) Additionatly pharmacological demyelination studies show an almost 
complete remyelination at chronic time points (Blakemore et al. 1977; Blakemore and 
Murray 1981; Jeffery and Blakemore 1995). These studies suggest that a delayed but 
sufficient endogenous remyelinating system exists. Finally, most of the conclusions drawn 
from pharmacological sparing of oligodendrocytes or white matter and on the persistence of 
“demyelinated” axons are based on correlations rather than true experiments.
A second assumption is that while the total destruction of phospholipids following SCI 
would obviously result in pathology of both axons and myelin, intrinsic phospholipase 
activity could potentially facilitate repair. It has been shown by several groups that myelin is 
a non-permissive substrate for neurite outgrowth (Niederost et al. 1999; Schwab and Caroni 
1988). Most of myelin’s inhibition has been attributed to proteins within the myelin fraction 
binding to the Nogo receptor complex (Filbin 2003). This raises the possibility that sPLA2 
activity following SCI could function as a clearance mechanism for myelin debris thus 
facilitating axon regeneration and functional recovery. Therefore inhibition of sPLA2 could 
possibly worsen SCI in vivo.
The results presented here suggest that the expression of sPLA2, particularly IIA, might 
participate in oligodendrocytes death mediated by several cytotoxic pathways. More 
importantly the blockade sPLA2 could provide a crucial therapeutic intervention for not only 
SCI but other CNS injuries in which H2O2, IL-1β and TNFα mediate damage. Whether 
inhibition of sPLA2 following SCI in vivo creates histological and functional sparing is 
under active investigation.
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Fig. 1. 
Changes in secretory PLA2 mRNA following SCI. A) Representative mRNA from 3 sham 
(lanes 2-4) or 3 SCI rats (lanes 5-7) 4hr post surgery. Lane 1 is a 100 bp ladder. Increases 
were seen in sPLA2-IIA and IIE with a decrease seen in sPLA2-X. B) Relative fold increase 
of sPLA2-IIA mRNA expression after real time Q-PCR (mean ± SD).
Titsworth et al. Page 21
Glia. Author manuscript; available in PMC 2015 June 10.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Fig. 2. 
sPLA2 protein expression following SCI. A) Representative western blots from sham or 
contused animals at 15 min, 4 hr, 1 day, or 1 wk post injury. The top panel in A shows time 
course of sPLA2-IB (16 & 14 kDa) showing no changes following SCI. SCI induced 
significant increase in sPLA2-IIA (15 kDa) and IIE (18 kDa) beginning at 4 hr and 1 day 
post injury, but returning to baseline by 1 week. Group X (13 kDa) showed no change in 
expression. Note lane 6 in IIA blot is equal amount of splenic protein for control. B - E) 
Quantification of western blots in A (n = 4/group, mean ± SD). (**p < 0.01 versus sham)
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Fig. 3. 
Immunohistochemical changes in sPLA2 expression following SCI. There was an increase 
in the sPLA2-IIA and IIE immunoreactivity following SCI (F & G) compare (B & C). No 
change in sPLA2-IB (A & E) or group X (D & H). Bar: A-H, 500 μm. Quantification of IB 
(I) and IIA (J) staining at the epicenter and at 5 mm increments rostrally and caudally show 
increases in sPLA2-IIA only and only at the epicenter. I-J; n = 5, mean ± SD; * p < 0.05; 
sham,  15 min , 1 hr , 4 hr . Changes was also seen in the ventral white matter 
between the sham (K - N) and 4 hr SCI (O - R). SCI induced a significant increase in 
sPLA2-IIA (L & P) and IIE (M & Q) within the white matter. However, there was little or 
no staining of sPLA2-X (N & R).
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Fig. 4. 
Co-localization of sPLA2 in oligodendrocytes post-SCI. Confocal images of 
immunofluorescent double labeling indicates that sPLA2-IB (A-C), IIA (D-F), IIE (G-I), but 
not X (J-L) are present within oligodendrocytes (CC1/APC) 4 hr following contusion. 
Orthoganol views of confocal image stacks. Scale bars: 20 μm for all.
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Fig. 5. 
sPLA2-IIA expression increases within oligodendrocytes following SCI and within the 
membrane fraction. sPLA2-IIA localizes to CC1-positive oligodendrocytes in both sham 
animals (A-C) and 4 hr post-SCI (D-F) with expression increasing post SCI (E versus B). G) 
Quantification of the sPLA2-IIA staining intensity in oligodendrocytes at the injury 
epicenter (n = 5 animals per group, mean ± SD; ** p<0.01). H) Western blots of subcellular 
fractions showing the increase of sPLA2-IIA is predominantly within the membrane 
fraction. I) Anti-caveolin antibody a membrane marker, anti-histone H1 a nuclear marker, 
and β-tubulin a cytosolic marker demonstrate the purity of the subcellular fractions.
Titsworth et al. Page 25
Glia. Author manuscript; available in PMC 2015 June 10.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Fig. 6. 
sPLA2-IIA selectively triggers cell death in Oligodendrocytes. Low levels of exogenously 
added sPLA2-IIA (0.01 and 0.1 μM; B & C) result in a loss of processes extending from the 
soma and at higher dose (2 μM; D) triggers a complete loss of process and cell death (phase 
contrast images). An 18.2 % increase in cytotoxicity as measured by an increase in LDH 
within the media (E), and a 33.1% decreased conversion of MTT (F) suggesting decreased 
cell survival. In contrast, 2 μM of sPLA2-IIA had no effect on cultured Schwann cells (G-H) 
or astrocytes (I-J) suggesting a specific sensitivity of oligodendrocytes to sPLA2-IIA.
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Fig. 7. 
H2O2 injury induces sPLA2-IIA expression in cultured oligodendrocytes. A) Western blots 
show a dose dependent increase in sPLA2-IIA 48 hr following a 30 min injury with vehicle, 
1mM, or 10mM of H2O2. B–J) Confocal images of oligodendrocytes 48 hr following 
treatment with vehicle (B-D) or 10 mM of H2O2 (E – J). Dead or dying cells showed either a 
fragmentation of the nuclei, loss of arborization, and micro-puncta (E – G) or a round nuclei, 
swelling of primary processes, and larger puncta (H – J). Bar: 50 μm.
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Fig. 8 
. sPLA2-IIA enzymatic inhibition by S3319 partially reverses H2O2 induced 
oligodendrocyte cell death. Pretreatment with 1.25 μM S3319, a sPLA2 inhibitor, decreases 
cytotoxicity of a 30 min, 10 mM H2O2 pulse by by 17.9 %. (n = 7 wells per group, all in 
vitro studies repeated in triplicate, mean ± SD; * p<0.05, ** p < 0.01, *** p < 0.001).
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Fig. 9. 
Blockade of sPLA2 in oligodendrocyte cultures prevents IL-1β and TNFα injury. A) 
Western blot showing time dependent sPLA2-IIA expression following treatment with 5 
ng/ml IL-1β and 10 ng/ml TNFα. B-G) Phase contrast images showing oligodendrocyte 
cultures 72 hr after injury with either vehicle, low doses (1 and 2 ng/ml) or high doses (5 and 
10 ng/ml) of IL-1β and TNFα. Cultures were either pretreated with vehicle (B-D) or 1.25 
μM S3319 (E-G). Note the decrease in oligodendrocyte process extension. H) IL-1β and 
TNFα injury resulted in very mild cytotoxicity at 72 hr, but a significant sparing when 
pretreated with the sPLA2 inhibitor S3319. I) Quantification of process area in (B-G) 
showing 1.25 μM S3319 significantly prevents the destruction of oligodendrocyte processes 
after cytokine injury.
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Table 1
Animal Usage and Experimental Groups
Sham 15 min 1 hr 4 hr 1 day 1 week
Contusion − + + + + +
mRNA n=3 n=3 n=3 n=3 n=3 n=3
Protein n=4 n=4 - n=4 n=4 n=4
Subcellular Protein n=4 - - n=4 - -
Histology n=5 n=5 - n=5 n=5 n=5
Cell Culture n=5 - - - - -
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Table 2
End point RT-PCR primers.
Gene Accession No. Primer sequence 5′-3′ Product (bp) Reference
PLA2-IB NM_031585 232–251: ACA ATC AGG CCA AGA AGC TG
462–481: ACG GCA TAG ACA GGA AGT GG
250 (Kolko, 2004)
PLA2-IIA NM_031598 687-707: TTGCCATTGTGGTGTGGGTGG
965-986: CAACTGGGCGTCTTCCCTTTGC
300 (Molloy, 1998)
PLA2-IIC NM_019202 1-20: CCTCCACCTCTCAAATGCTG
231-250: CATTGCTGTTCCAGCCTTTT
250 (Molloy, 1998)
PLA2-IID NM_001013428 1–20: CTGCCTTGCTCTGTGCTGGA
234-253: CCATCGATCTTCAGGTGGGC
254
PLA2-IIE XM_238421 401-419: GTGGGAACCTGGTCCAGTT
667-687: GGCAGCTCTCTTGTCACACTC
285 (Kolko, 2004)
PLA2-IIF XM_233589 1-20: ATGAAGGAGGTTGAGTTTGC
242-261: TGGAATATCACAGAGCTGGA
262
PLA2-III XM_223553 12-36: TATACTTGAGTATAAGACCTCGTGT
243-262: TCAGAAGAATTGAGCAGGAC
251
PLA2-V NM_017174 380-401: CCCTAAGGATGGCACTGATTGG
530-551: CCCTAAGGATGGCACTGATTGG
172 (Molloy, 1998)
PLA2-X NM_017176 461–481: TCC CCT CGG TTT TAT GTG AG
640–660: GCT CCA CAG GCT CAT AGT CC
200 (Kolko, 2004)
PLA2-XIIa XM_342340 144-163: CCAGGAACAGGACCAGACCA
373-393: CTTGGTCAGGGAAGGGATGC
250
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